Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Jul 10, 2023
Date Accepted: Oct 7, 2024

The final, peer-reviewed published version of this preprint can be found here:

A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study

Ehrler F, Gschwind Tran L, Hagberg H, Meyer P, Blondon K

A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study

JMIR Cardio 2025;9:e50693

DOI: 10.2196/50693

PMID: 39864094

PMCID: 11781755

Smart-Meds, a medication management app for patients after an acute coronary syndrome: A pilot pre-post study

  • Frederic Ehrler; 
  • Liliane Gschwind Tran; 
  • Hamdi Hagberg; 
  • Philippe Meyer; 
  • Katherine Blondon

ABSTRACT

Background:

Medication non-adherence remains a significant challenge in the management of chronic conditions, often leading to suboptimal treatment outcomes and increased healthcare costs. Innovative interventions that address the underlying factors contributing to non-adherence are needed. Gamified mobile applications have shown promise in promoting behavior change and engagement

Objective:

This pilot study aimed to evaluate the efficacy and usability of a gamified mobile application that employed a narrative storytelling approach to enhance medication adherence among patients following Acute Coronary Syndrome (ACS). The study aimed to assess changes in participants' beliefs about medication and self-reported adherence before and after the intervention. Additionally, user feedback regarding the narrative component of the app was gathered.

Methods:

Eighteen patients who recently experienced ACS were recruited for a one-month intervention using the gamified app. Participants' beliefs about medication and self-reported adherence were assessed using standardized scales pre- and post-intervention. The app's usability was also evaluated through a post-intervention questionnaire. Statistical analyses were performed to determine the significance of changes in belief and adherence scores.

Results:

The results did not indicate a significant improvement in participants' beliefs about medication following the intervention. However, self-reported adherence significantly improved (p < 0.05) after the intervention, with participants demonstrating a greater self-efficacy to their prescribed medication regimen. The usability evaluation revealed positive feedback, indicating a good usability rating for the gamified app. However, the narrative storytelling component of the app was not favored by the participants, as indicated by their feedback.

Conclusions:

This pilot study suggests that a gamified mobile application employing narration may effectively enhance medication self-efficacy and positively influence patients' beliefs about medication following ACS. However, the narrative component of the app did not receive favorable feedback from participants. Future research should focus on exploring alternative methods to engage participants in the app's narrative elements while maintaining the positive impact on adherence and beliefs about medication observed in this study.


 Citation

Please cite as:

Ehrler F, Gschwind Tran L, Hagberg H, Meyer P, Blondon K

A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study

JMIR Cardio 2025;9:e50693

DOI: 10.2196/50693

PMID: 39864094

PMCID: 11781755

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.